| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Interim CEO | Director
6 companies
Madaus Martin D serves as a Director at LAB and has filed Form 4s across 6 companies. Across recent SEC filings that breaks down to 9 buys and 83 sells. Those positions are worth an estimated $2.1M at current prices.
Historically, Madaus Martin D's trades have earned a strong insider score of 72/100 across 8 rated trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +15.4%.
The biggest single holding is AZTA (~$1.5M) as Interim CEO. Net of sales, the recent Form 4 record there shows accumulation of 4,940 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | RGEN Repligen Corp | Director | Buy | 1,800 | $112.13 | $201,830.40 | New | +30.1% | +47.1% | |
| May 7, 2025 | HOLX Hologic Inc | Director | Buy | 5,445 | $55.24 | $300,760.02 | New | +22.4% | - | |
| Nov 19, 2024 | AZTA Azenta, Inc. | Director | Buy | 4,940 | $40.77 | $201,403.80 | +200.4% | +8.5% | -26.6% | |
| Jun 14, 2024 | RGEN Repligen Corp | Director | Buy | 1,615 | $124.94 | $201,776.10 | +53.9% | +13.0% | +1.5% | |
| May 8, 2023 | RGEN Repligen Corp | Director | Buy | 1,500 | $158.84 | $238,260.00 | +1,351% | +9.4% | +7.1% | |
| Aug 10, 2022 | Director | Buy | 89,667 | $8.43 | $755,543.11 | +54.4% | +9.0% | +182.5% | ||
| Nov 5, 2020 | Director | Sale+OE | 2,972 | $40.81 | $121,281.40 | -20.2% | - | - | ||
| Oct 20, 2020 | Director | Sale+OE | 3,200 | $43.58 | $139,456.00 | -21.5% | - | - | ||
| Oct 7, 2020 | Director | Sale+OE | 3,200 | $36.82 | $117,828.96 | -21.5% | - | - | ||
| Sep 29, 2020 | Director | Sale+OE | 3,200 | $32.80 | $104,968.67 | -22.2% | - | - |